Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
T.MAN Pharmaceutical PCLBKK:TMAN -0.96%18 Forward PE Ratio is 7.69 as of Sep. 14, 2026. GuruFocus rates BKK:TMAN with a GF Score™ of 18/100. Among 411 Drug Manufacturers companies, T.MAN Pharmaceutical PCL ranks better than 84.67% on this metric.
T.MAN Pharmaceutical PCL (BKK:TMAN) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
T.MAN Pharmaceutical PCL Forward PE Ratio Related Terms
T.MAN Pharmaceutical PCL Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T.MAN Pharmaceutical PCL Forward PE Ratio Chart
T.MAN Pharmaceutical PCL Annual Data
Trend
2025-12
Forward PE Ratio
7.25
T.MAN Pharmaceutical PCL Quarterly Data
2025-12
2026-03
2026-06
Forward PE Ratio
7.25
10.48
8.57
BKK:TMAN vs ZTS, UTHR, VTRS: Forward PE Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, T.MAN Pharmaceutical PCL's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T.MAN Pharmaceutical PCL Forward PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, T.MAN Pharmaceutical PCL's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where T.MAN Pharmaceutical PCL's Forward PE Ratio falls into.
T.MAN Pharmaceutical PCL Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Forward PE Ratio of 7.69 as of Sep. 14, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on T.MAN Pharmaceutical PCL and its competitors. According to the industry distribution chart, T.MAN Pharmaceutical PCL ranks #63 out of 411 companies in the Drug Manufacturers industry, placing it in the top 15.3%.
Is T.MAN Pharmaceutical PCL's Forward PE Ratio too high?
T.MAN Pharmaceutical PCL's current Forward PE Ratio is 7.69. The Drug Manufacturers industry median Forward PE Ratio is 14.68. T.MAN Pharmaceutical PCL's value of 7.69 is 47.6% below this industry median. Based on the distribution chart, T.MAN Pharmaceutical PCL ranks #63 out of 411 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Forward PE Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, T.MAN Pharmaceutical PCL ranks #63 out of 411 companies for Forward PE Ratio. This places T.MAN Pharmaceutical PCL in the top 15% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 14.68. T.MAN Pharmaceutical PCL's value of 7.69 is 47.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Drug Manufacturers company?
The median Forward PE Ratio among Drug Manufacturers companies is 14.68, based on 411 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. T.MAN Pharmaceutical PCL's current Forward PE Ratio of 7.69 is 47.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on T.MAN Pharmaceutical PCL and its competitors. For the Drug Manufacturers industry, the median Forward PE Ratio is 14.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. T.MAN Pharmaceutical PCL's current Forward PE Ratio is 7.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Forward PE Ratio of 7.69. The current Forward PE Ratio is 7.69 and 47.6% below the Drug Manufacturers industry median of 14.68. T.MAN Pharmaceutical PCL's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Forward PE Ratio is 7.69 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
18GF Score
Get the complete analysis for BKK:TMAN
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TMAN has been successfully added to your 
